جستجوی استاد راهنمای دانشگاهی

Gustavo Nader, Ph.D., is a Professor of Kinesiology at The Pennsylvania State University's College of Health and Human Development, where he holds the Dorothy Foehr Huck and J. Loyd Huck Endowed Chair in Molecular, Cellular and Integrative Physiology. His research laboratory at 101 Noll Lab focuses on molecular mechanisms of skeletal muscle adaptation, employing human, animal, and cellular models to investigate ribosome biogenesis, transcriptional regulation, and muscle growth control in contexts ranging from exercise hypertrophy to cancer cachexia. Dr. Nader's research examines fundamental processes including: Ribosome biogenesis and its role in muscle growth regulation Epigenetic control of RNA Polymerase I activity Molecular pathways in mechanical overload-induced hypertrophy Tumor-induced muscle wasting mechanisms Biomimicry approaches inspired by hibernator physiology His work spans exercise physiology, cancer biology, and environmental stress responses. Analysis of his 15 most recent publications (2015-2025) reveals predominant themes in muscle hypertrophy mechanisms, cancer cachexia pathophysiology, ribosomal function analysis, and environmental stress impacts on muscle. His work consistently integrates molecular techniques with physiological models across species. Notable scientific recognitions include: Dorothy Foehr Huck and J. Loyd Huck Chair appointment (2024) Huck Institutes Leadership Fellowship (2025-2026) Dr. Nader leads an active research team investigating muscle plasticity, with current projects funded through the Huck Institutes of the Life Sciences. He collaborates extensively through Penn State's Integrative and Biomedical Physiology graduate program and Center for Cellular Dynamics.

• Skeletal Muscle Growth
• Ribosome Biogenesis
• Exercise Physiology
• +۴ مورد دیگر

Adam Feinberg is a Professor in the Departments of Biomedical Engineering and Materials Science and Engineering at Carnegie Mellon University (CMU). He leads the Regenerative Biomaterials & Therapeutics Group, focusing on cell-material interactions, 3D bioprinting, and bioengineered tissues. His work integrates nanofabrication, molecular biology, and 3D imaging to address challenges in muscle repair, corneal regeneration, and cancer. Key innovations include the FRESH bioprinting platform, enabling soft ECM gel-based constructs, and ECM shrink-wrapping techniques for cell encapsulation. Feinberg holds a Ph.D. and MS in Biomedical Engineering from the University of Florida (2004, 2002) and a BS in Materials Science and Engineering from Cornell University (1999). He has secured major grants, including ARPA-H funding for diabetes treatments and Canada’s New Frontiers Fund for heart disease therapies. His research has led to over 45 peer-reviewed articles and 20 patents. His scientific awards include the NIH Director’s New Innovator Award and NSF CAREER Award. Media highlights include breakthroughs in vascularized tissue models and biodegradable actuators. Feinberg collaborates widely, advancing clinical translation of bioprinted tissues and sustainable bio-bots.

• Biomedical Engineering
• Tissue Engineering
• 3D Bioprinting
• +۶ مورد دیگر

Dijin Xu is an Associate Research Scientist in the Department of Microbial Pathogenesis at Yale School of Medicine, Yale University. His research focuses on lipid metabolism, immunology, and molecular mechanisms underlying metabolic disorders and host-pathogen interactions. He holds a PhD from Tsinghua University (2016). Education: PhD in Microbiology, Tsinghua University, 2016 Research Interests: Dr. Xu’s work spans immunology (e.g., B cell biology and somatic hypermutation), lipid metabolism (lipid droplet dynamics and adipose tissue homeostasis), and virology (antiviral defense mechanisms against SARS-CoV-2). His studies integrate cellular biology, molecular genetics, and biochemical approaches to understand disease processes. Publications Overview: His recent work explores mechanisms of lipid droplet regulation, metabolic disorder prevention, and immune system function. Notable contributions include studies on Rab GTPases in lipid storage and ELOF1’s role in antibody diversification. Labs & Affiliations: He is affiliated with the West Campus Integrative Science & Technology Center at Yale University, focusing on interdisciplinary research in cellular and molecular biology.

• Immunology
• Lipid Metabolism
• Infectious Diseases
• +۳ مورد دیگر

Tommy Lundberg is a Senior Lecturer and Docent in Physiology at Karolinska Institutet. He works at the Department of Laboratory Medicine, Division of Clinical Physiology. His email address is tommy.lundberg@ki.se, and his postal address is H5 Laboratoriomedicin, H5 Klinisk Fysiologi Gustafsson, 141 52 Huddinge. Lundberg is affiliated with the university library and has held positions since 2022. Research Interests: Lundberg's research focuses on skeletal muscle mass and function adaptation, particularly in athletic performance, disease contexts, aging, and transgender individuals undergoing hormone therapy. He investigates molecular, metabolic, morphological, and functional responses to resistance and aerobic exercises. His work also explores biological maturity selection biases in youth sports, bio-banding applications in soccer and ice hockey, and the impact of anti-inflammatory drugs on muscle hypertrophy. Article Trends: Lundberg's recent publications (2025–2024) cover topics like sex differences in disc golf, muscle atrophy in space exposome, longitudinal hormone therapy effects in transgender individuals, and bio-banding in youth sports. Earlier works delve into molecular pathways in muscle hypertrophy, concurrent training effects, mitochondrial function, and imaging techniques (CT/MRI) for muscle assessment. Scientific Recognition: Most prominent young researcher in Sport Science, Swedish Central Association for Sport Promotion (SCIF), 2017 Teaching and Editorial Roles: Lundberg teaches human physiology and sports science in nursing, physiotherapy, and biomedical analytics programs. He leads a contract education course in advanced exercise physiology and contributes to a PhD course on scientific writing. He is an Associate Editor for Frontiers in Physiology - Exercise Physiology (2022) and a member of the editorial board for Translational Exercise Biomedicine (2024). Collaborations and Expertise: He collaborates with the Swedish Football Association and Swedish Ice Hockey Association on bio-banding studies. Lundberg served as an invited speaker at the ACSM Annual Meeting (2024) on transgender athletes and as an expert panelist for World Rugby's transgender workshop (2020). His supervision includes Andrea Tryfonos (2021) and thesis evaluations at Mid Sweden University and Linköping University.

• Physiology
• Sports Science
• Molecular Biology
• +۳ مورد دیگر

Gustavo Alberto Nader is a Professor of Kinesiology at The Pennsylvania State University , holding the Dorothy Foher and J. Lloyd Huck Chair in Molecular, Cellular and Integrative Physiology. His research focuses on skeletal muscle growth control , ribosome biogenesis , and transcriptional/epigenetic regulation in health and disease contexts. Affiliated with the Huck Institutes of the Life Sciences and College of Health and Human Development Principal Investigator on NIH-funded projects examining ribosomal control of muscle mass Research Interests span molecular mechanisms of muscle adaptation to exercise, cancer cachexia, chronic disease impacts on muscle, and cross-species Wnt signaling regulation by CO₂ levels. Key methodologies include human/animal/cell models, ribosomal analysis, and epigenetic profiling. Publication Trends show sustained focus on: Ribosome biogenesis in muscle hypertrophy (2012–2025) Cancer-induced muscle wasting mechanisms (2015–2024) CO₂/Wnt pathway interactions (2015–2019) Exercise-induced transcriptional responses (2001–2016) Scientific Awards include the Huck Chair, while his Grants & Collaborations involve NIH-funded studies on transcriptional/epigenetic mechanisms (2019–2026) with cross-disciplinary teams in physiology, oncology, and respiratory medicine.

• Skeletal Muscle Physiology
• Ribosome Biogenesis
• Transcriptional Regulation
• +۴ مورد دیگر

Dr. Stephanie de Alcantara Fernandes is a Minerva Fast Track Group Leader at the Max Planck Institute for Biology of Ageing in Cologne, Germany, where she leads research on muscle metabolism and aging. Her laboratory investigates how spatial and functional regulation of mTORC1 signaling influences skeletal muscle health, growth, and regeneration throughout the lifespan, with implications for understanding and promoting healthy aging. Dr. Fernandes completed her academic training through a distinguished path: PhD in Biology (Summa cum laude, with distinction), University of Cologne/Max Planck Institute for Biology of Ageing (2017-2023) Master of Science in Genetics, University of São Paulo (2015-2017) Bachelor of Science in Biological Sciences, University of São Paulo (2009-2014) Exchange year at University of Birmingham, UK (2013) Her research focuses on skeletal muscle biology, particularly the balance between anabolic and catabolic processes that maintain muscle health. Dr. Fernandes investigates how mTORC1 (mechanistic Target of Rapamycin Complex 1), a central signaling hub, is spatially organized within cells to selectively regulate specific cellular functions in response to different nutrient sources. Her work reveals that mTORC1 is not simply "on or off" but can be finely tuned to control distinct processes in different cellular compartments, particularly in skeletal muscle cells. A key aspect of her research examines how these regulatory mechanisms change with age, contributing to age-related muscle loss (sarcopenia). By understanding the molecular basis of muscle maintenance and regeneration, her laboratory aims to identify targets for interventions that could promote healthier aging and prevent age-related decline in muscle function. Analysis of Dr. Fernandes' publication record shows a clear trajectory of increasingly independent research focused on mTORC1 signaling, nutrient sensing, and their roles in aging and muscle biology. Her most recent work demonstrates sophisticated understanding of mTORC1's spatial regulation, revealing how different pools of mTORC1 respond to distinct amino acid sources to control specific cellular processes. This research bridges fundamental cell biology with translational applications for aging-related conditions. Dr. Fernandes has received numerous prestigious awards recognizing her scientific excellence: Minerva Fast Track Fellowship (2025) - Group Leader Position for Outstanding Female Scientists from Max Planck Society Graduate School for Biological Sciences (GSfBS) doctoral award for 2023 (2025) World Muscle Society Fellowship (2016) Cologne Graduate School of Ageing Research fellowship (2017-2020) Master's scholarship from São Paulo Research Foundation (2015-2017) Science Without Borders Scholarship from Brazilian Council for Scientific and Technological Development (2013) As a newly appointed Group Leader through the Minerva Fast Track program, Dr. Fernandes is establishing her independent research program with substantial institutional support. Her laboratory combines advanced techniques including high-throughput omics approaches (proteomics, metabolomics), molecular biology, biochemistry, cell biology, and super-resolution microscopy. She utilizes multiple model systems including mouse models, skeletal muscle cell lines, and iPSC-derived skeletal muscle cells to identify evolutionarily conserved mechanisms relevant to human health. Dr. Fernandes leads the Minerva Fast Track Group at the Max Planck Institute for Biology of Ageing, which focuses specifically on "Muscle metabolism and aging." Her team investigates how selective mTORC1 signaling is coordinated between different skeletal muscle cell types and how it changes with age, with the ultimate goal of understanding how muscle health can be maintained throughout life.

• Muscle Metabolism
• Aging Research
• mTORC1 Signaling
• +۶ مورد دیگر

Dr. Meng Deng is an Associate Professor in Agricultural & Biological Engineering at Purdue University, specializing in biomaterials, regenerative engineering, and drug delivery. He holds a B.E. from Tsinghua University and a Ph.D. from the University of Virginia, with postdoctoral training at the University of Connecticut Health Center and MIT. His research focuses on designing polymeric biomaterials for musculoskeletal tissue regeneration and controlled drug delivery, including nanoparticle-based therapies for obesity and metabolic disorders. He has received awards such as the Society for Biomaterials STAR Award and Young Scientist Award (2012 World Biomaterials Congress). His work integrates nanotechnology and bioengineering to develop inductive materials that modulate cell behavior. Current research interests include bioactive hydrogels, muscle regeneration, and browning of white adipose tissue. Dr. Deng advises postdoctoral fellows, graduate students, and undergraduates in his lab at Regenerative Matter, with publications available via Google Scholar. Affiliations: Purdue University Department of Agricultural & Biological Engineering Key Research Themes: Biomaterials, Drug Delivery, Nanotechnology His lab explores applications in musculoskeletal repair, metabolic engineering, and regenerative medicine. Recent studies include gamma-secretase inhibitors for obesity therapy and glycosaminoglycan-based scaffolds for muscle regeneration. Collaborations include work with MIT’s Robert Langer and University of Connecticut’s Cato Laurencin.

• Biomaterials
• Regenerative Engineering
• Drug Delivery
• +۴ مورد دیگر

Prof. Dr. Katrien De Bock is a Full Professor and Deputy Head of the Department of Health Sciences and Technology at ETH Zurich. Her research focuses on angiogenesis, metabolic crosstalk in muscle microenvironments, and the impact of exercise on muscle regeneration. She leads a team investigating cellular interactions in skeletal muscle, particularly how metabolic signals regulate blood vessel growth and muscle repair. Key areas include understanding fibroadipogenic progenitors' role in muscle physiology, the role of histamine in exercise responses, and age-related muscle decline. Her work integrates molecular biology, single-cell transcriptomics, and computational approaches to dissect mechanisms underlying tendon pathologies, ischemic muscle injury, and metabolic adaptations to exercise. She supervises Master's programs in Human Movement Science and collaborates on projects involving muscle stem cell therapies and vascular engineering. Prof. De Bock also explores interventions like NAD+ precursors to counteract age-related sarcopenia and promotes translational research in regenerative medicine. Research Interests: Exercise-induced metabolic pathways in muscle repair Angiogenesis regulation in health and disease Hypoxia signaling in tendons and muscles Epigenetic modifications during tissue regeneration Stem cell fate determination in muscle microenvironments Notable Projects: Developing AI-driven histologic analysis for tendinopathy diagnosis Mapping the human brain vasculature at single-cell resolution Testing sulfur amino acid restriction to enhance exercise capacity

• Muscle Microenvironment
• Angiogenesis
• Metabolic Crosstalk
• +۴ مورد دیگر

Kristine Urschel serves as Assistant Dean for Instruction and Professor in the Department of Animal and Food Science at the University of Kentucky's Martin-Gatton College of Agriculture, Food and Environment. Since joining the faculty in 2008 with a 60% research and 40% teaching appointment, she has established a prominent research program focused on equine nutrition and physiology, particularly protein and amino acid metabolism across the equine lifespan. Her educational background includes a Post-doctoral Fellowship at Virginia Polytechnic Institute and State University (2008), a Ph.D. in Philosophy from the University of Alberta (2007) with thesis research on arginine metabolism in neonatal piglets, and a B.S. in Animal Science from the University of Alberta (2002) where she received the Dean's Medal in Agriculture as the top graduate in the Faculty of Agriculture, Forestry and Home Economics. Dr. Urschel's research investigates protein and amino acid requirements in horses of all ages, with particular emphasis on muscle protein synthesis regulation and aging effects. She employs advanced methodologies including isotopic tracer techniques, HPLC, Western blot, ELISA, RT-PCR, and physiological assays such as hyperinsulinemic euglycemic clamps to study metabolic responses to diet, disease, and physiological states. Her work bridges comparative animal nutrition with clinical equine applications. Analysis of her publication record (2005-2014) reveals consistent focus on metabolic regulation in equines and comparative models, with recent work examining insulin dynamics, amino acid utilization, and aging impacts on protein synthesis. Key thematic areas include metabolic disorders like equine Cushing's disease, dietary protein optimization across life stages, and interspecies differences in amino acid metabolism. Her significant scientific recognition includes: Multiple American Society of Nutrition awards (2005-2007) including Procter & Gamble Graduate Student Competition wins Banff Pork Seminar Graduate Student Competition victory (2007) Canadian Society of Animal Science Graduate Student Oral Presentation First Place (2005) Dean's Medal in Agriculture as undergraduate top student While specific grant details aren't provided, her research program involves extensive collaboration with veterinary scientists and nutrition researchers. She mentors graduate students through research projects and teaches core courses including Animal Physiology, Equine Science, and Macronutrient Metabolism, integrating her laboratory findings into pedagogy. Her research environment features specialized capabilities for conducting metabolic studies including isotopic tracer techniques, physiological clamp procedures, and advanced biochemical analyses on equine subjects, supporting investigations into nutrient requirements throughout the horse's lifespan from weanlings to geriatric animals.

• Equine Science
• Animal Physiology
• Protein Metabolism
• +۳ مورد دیگر

Dr. C. Brooks Mobley is an Assistant Clinical Professor at the School of Kinesiology, Auburn University. He directs the TigerFit Health & Fitness Laboratory and serves as Associate Director of the Nutrabolt Applied and Molecular Physiology Lab. With a Ph.D. in Kinesiology from Auburn University and postdoctoral training at the University of Kentucky, he specializes in skeletal muscle physiology and sports nutrition research. B.S. in Animal & Dairy Sciences (Auburn University) M.Ed. in Exercise Physiology (Auburn University) Ph.D. in Kinesiology (Auburn University) Postdoctoral Fellowship at University of Kentucky's College of Medicine His research explores molecular mechanisms of muscle plasticity, focusing on: Cellular adaptations to exercise training Ergogenic effects of sports supplements Muscle atrophy prevention strategies Mechanisms of skeletal muscle hypertrophy Angiogenesis in recovery scenarios Muscle-bone interaction dynamics Recent publications demonstrate expertise in: Mitochondrial adaptations to resistance training Epigenetic regulation of muscle growth Microbiome-exercise interactions Proteomic responses to disuse atrophy Firefighting occupational physiology Supplement efficacy studies Laboratory Leadership: TigerFit Health & Fitness Laboratory Nutrabolt Applied and Molecular Physiology Lab

• Skeletal Muscle Physiology
• Molecular Mechanisms of Exercise Training
• Sports Supplements
• +۳ مورد دیگر

Michael Roberts is a Professor in the School of Kinesiology at Auburn University, serving as Director of both the Molecular and Applied Sciences Laboratory and the Applied Physiology Laboratory. His research integrates nutrition and exercise science to investigate cellular biomarkers and whole-body physiological responses using cell culture, rodent models, and human studies. His primary research interests include Exercise Physiology , Nutrition Science , and Skeletal Muscle Adaptation , with emphasis on resistance training mechanisms, dietary supplementation, and molecular pathways underlying muscle hypertrophy/atrophy. His work employs advanced techniques in molecular biology to address questions relevant to athletic performance, aging, and clinical rehabilitation. Analysis of his recent publications reveals consistent focus on resistance training adaptations, creatine/nitrate supplementation, skeletal muscle remodeling, and microbiome-exercise interactions. His research demonstrates methodological diversity spanning cellular models, rodent studies, and human clinical trials, with particular attention to molecular mechanisms in aging populations and performance optimization. Dr. Roberts actively mentors through laboratory leadership roles, though specific student names aren't documented in provided materials. His editorial positions in physiology journals and frequent conference lectures indicate significant academic influence beyond direct research outputs. The Molecular and Applied Sciences Laboratory and Applied Physiology Laboratory form collaborative hubs for interdisciplinary research, utilizing techniques ranging from molecular analysis to whole-body physiological assessment. These facilities support investigations into exercise-nutrition interactions across diverse populations from athletes to older adults.

• Exercise Physiology
• Nutrition Science
• Skeletal Muscle Physiology
• +۲ مورد دیگر

Dr. Evelyn Parr is a Senior Research Fellow at the Mary MacKillop Institute for Health Research, Australian Catholic University (ACU), where she conducts translational research in the Exercise and Nutrition Research Program. Her work focuses on the interplay between exercise, nutrition, and metabolic health, particularly in the context of obesity, type 2 diabetes, and body composition. Her educational background includes undergraduate degrees in Physical Education and Science from the University of Otago, New Zealand, followed by a Master’s in Exercise Metabolism and a PhD titled 'Exercise and nutrient interactions: Effects on skeletal muscle and body fat mass,' awarded in 2016 from ACU. Dr. Parr's research centers on time-restricted eating, nutrient timing, and exercise prescription to improve glycemic control and prevent muscle loss, especially in aging and overweight populations. She investigates how manipulating the timing of food intake and physical activity can optimize metabolic outcomes. Her work often involves randomized controlled trials and collaborations with leading institutions like La Trobe University and the University of Adelaide. The recent publication trends highlight a strong focus on time-restricted eating, circadian metabolism, and exercise timing. Her studies integrate nutrition, physiology, and clinical outcomes, contributing to the growing field of chrononutrition and metabolic disease prevention. Best paper of 2020, Exercise and Sports Science Reviews (awarded 2021) International Travel Award, European Association for the Study of Diabetes (EASD) Conference (2019) Australian Postgraduate Award Scholarship (2014–2015) Best student presentation, SESNZ conference (2014) ESPEN Early Career Fellowship (2018–2019) Dr. Parr has secured significant research funding, including an NHMRC Medical Research Future Fund grant for the TREAT study on preventing type 2 diabetes through time-restricted eating. She supervises higher degree research students and collaborates extensively with Prof John Hawley, Dr Brooke Devlin, and A/Prof Leah Brennan. Her editorial roles include Topic Editor for Nutrients and reviewer for top journals such as Diabetologia , Obesity , and Medicine and Science in Sports and Exercise . She is an active member of professional organizations including Exercise and Sports Science Australia (ESSA), ESPEN, EASD, and The Obesity Society, and contributes to grant review panels for Diabetes Australia and NHMRC.

• Exercise Physiology
• Nutrition
• Metabolism
• +۷ مورد دیگر

Dr. Ant Shepherd is an Associate Professor in Clinical Exercise Physiology at the University of Portsmouth, affiliated with the School of Psychology, Sport and Health Sciences within the Faculty of Science & Health. He also contributes to the Institute of Life Sciences and Healthcare and the Centre for Integrated Health and Wellbeing. Dr. Shepherd holds an ORCID identifier (0000-0001-6392-7944) and is actively involved in PhD supervision and academic leadership. Education: BSc (Hons) Sports Science (Bangor University), MSc Exercise Rehabilitation (Bangor University), PhD (University of Exeter, 2015) Postdoctoral Experience: University of Exeter Medical School Research Interests: Dr. Shepherd focuses on using novel interventions—such as nutritional strategies and exposure to extreme environments—to improve metabolic and cardiovascular health. His work emphasizes patient-centered outcomes, particularly in chronic conditions like type 2 diabetes, cystic fibrosis, and chronic obstructive pulmonary disease. He explores disease pathophysiology to identify therapeutic strategies. Publications: His recent work includes studies on cardiovascular function in cystic fibrosis patients, the effects of ketone esters in diabetes, and the role of nitrate in vascular health. Articles often employ randomized controlled trials and observational designs. Awards: Runner-up, Inaugural Annual Review Prize of the Physiological Society (2021) Advising & Grants: Supervises multiple PhD students and postdocs. Serves as a grant reviewer for the Medical Research Council and reviews for journals including Journal of Applied Physiology and Thorax . Active in collaborative projects, such as investigating climate adaptation strategies in diabetes and the effects of passive heating on older adults. Labs & Teams: Leads research teams in translational exercise physiology and collaborates internationally on projects related to cystic fibrosis, diabetes, and vascular health.

• Clinical Exercise Physiology
• Metabolic Health
• Cardiovascular Function
• +۵ مورد دیگر

Danielle Levitt, PhD, CSCS*D, serves as an Assistant Professor in the Department of Kinesiology & Sport Management at Texas Tech University and is actively affiliated with the Institute for One Health Innovation. Her research program focuses on metabolic health, investigating how lifestyle factors contribute to dysfunction in health and disease while developing targeted intervention strategies to improve clinical outcomes. Dr. Levitt's core research interests include: Skeletal muscle physiology and bioenergetics Alcohol misuse and its metabolic consequences Glycemic control mechanisms Inter-organ crosstalk in disease states Cardiometabolic risk in vulnerable populations (e.g., people living with HIV, first responders) Exercise physiology interventions Analysis of her recent publications reveals dominant themes in alcohol-pathogen interactions, skeletal muscle regeneration under metabolic stress, and cardiometabolic risk modulation. Her work frequently employs SIV-infected macaque models to study HIV-alcohol comorbidities, explores mTOR signaling pathways in muscle adaptation, and investigates dietary impacts on viral pathogenesis including SARS-CoV-2 susceptibility. Methodologically, she integrates molecular biology, exercise physiology, and epidemiological approaches across diverse populations. No scientific awards were mentioned in the provided documentation. Information regarding Dr. Levitt's graduate student advising, grant funding history, or specific laboratory resources was not included in the source materials. Her research appears to operate through collaborative frameworks within the Institute for One Health Innovation. Dr. Levitt maintains active research operations at Texas Tech University's Institute for One Health Innovation, where she contributes to interdisciplinary initiatives addressing complex health challenges at the human-animal-environment interface through metabolic and physiological research.

• Metabolic Health
• Skeletal Muscle Physiology
• Alcohol Misuse
• +۵ مورد دیگر

Daniel J. Siegwart holds the W. Ray Wallace Distinguished Chair in Molecular Oncology Research and serves as Professor at the University of Texas Southwestern Medical Center. He maintains dual appointments in the Department of Biomedical Engineering and Department of Biochemistry, and is affiliated with the Simmons Comprehensive Cancer Center. Dr. Siegwart directs both the Program in Genetic Drug Engineering and the Drug Delivery Program in Biomedical Engineering, while also serving as Co-Director of the Chemistry and Cancer Program. Dr. Siegwart's research focuses on developing advanced lipid and polymer-based systems with precise control over structure and responsiveness for applications in drug delivery, imaging, genetic diseases, and cancer. His work spans nano-based drugs, personalized medicine, and cancer immunology, with particular emphasis on creating targeted delivery systems for nucleic acid therapeutics. His laboratory pioneers innovations in lipid nanoparticle technology, selective organ targeting (SORT) systems, and novel approaches to overcome delivery barriers for genetic medicines. Analysis of Dr. Siegwart's recent publications reveals a strong focus on advancing lipid nanoparticle technology for organ-specific delivery of nucleic acids. His research group has made significant contributions to understanding structure-activity relationships of ionizable lipids, developing multi-organ targeting strategies, and creating solutions for repeated administration of mRNA therapeutics. Current work emphasizes expanding delivery capabilities beyond the liver to target lungs, spleen, skeletal muscle, and skin for treating genetic diseases and cancer. National Academy of Inventors (NAI) Fellow (2024) National Academy of Medicine (NAM) Emerging Leaders in Health and Medicine (ELHM) Scholar (2024) Controlled Release Society (CRS) College of Fellows (2023) American Institute for Medical and Biological Engineering (AIMBE) College of Fellows (2022) Howard Hughes Medical Institute (HHMI) Gilliam Fellowship for Advanced Study (2021) Dr. Siegwart has secured significant research funding including the American Cancer Society Research Scholar award, CPRIT Scholar Award, and NIH funding. He has co-founded multiple biotechnology companies including Signify Bio, Jumble Therapeutics, and ReCode Therapeutics, translating his academic research into clinical applications. His laboratory maintains active collaborations with leading institutions and pharmaceutical companies to advance nucleic acid delivery technologies. The Siegwart laboratory operates as a multidisciplinary research team at the intersection of chemistry, materials science, and biomedical engineering. The group maintains state-of-the-art facilities for nanoparticle formulation, characterization, and in vivo testing, with particular expertise in lipid chemistry, polymer synthesis, and nucleic acid delivery. Current research directions include developing next-generation delivery systems for CRISPR-based gene editing, creating tissue-specific mRNA vaccines, and engineering novel approaches to treat genetic disorders and cancer.

• Drug Delivery
• Nanotechnology
• Cancer Research
• +۶ مورد دیگر